The WHO chief flew to Kampala with a message and a $518 million plan. Uganda’s border closure, well-intentioned as it is, may be making the outbreak harder to fight — not easier.
Shutting a border is the kind of decision that looks decisive in a cabinet room. On the ground, in the trading towns and farming communities straddling the frontier between Uganda and the Democratic Republic of Congo, it tends to produce something rather different: rotting goods, desperate people finding unofficial crossings, and health workers unable to move the supplies and personnel that an outbreak response urgently requires.
That is the tension at the heart of what is now one of the world’s most serious active public health emergencies. On Monday, WHO Director-General Tedros Adhanom Ghebreyesus visited an Ebola isolation unit at a hospital in Kampala and called on Uganda to reconsider its border closure with the DRC, praising the country’s response as prompt and capable whilst making clear that the closure itself was counterproductive.
The appeal lands in difficult circumstances. Uganda is not wrong to be frightened. The virus it is dealing with is rare, rapidly spreading, and has no approved treatment or vaccine.
What Is Happening and Why It Is Serious
On 15 May 2026, the DRC and Uganda simultaneously declared an outbreak of Ebola caused by the Bundibugyo virus — Congo’s 17th Ebola outbreak in recorded history. Within two days, the WHO Director-General declared it a public health emergency of international concern. That designation — the highest alarm level in global health governance — has been used sparingly. Its invocation here reflects the genuine severity of what is unfolding.
As of early June, Congo has recorded 381 confirmed cases and 62 confirmed deaths, with Uganda registering 19 confirmed cases and two deaths. The outbreak is already the fourth largest on record. The pace of spread has alarmed epidemiologists. The epidemic went undetected for weeks, the Africa Centres for Disease Control and Prevention acknowledged, leaving health authorities behind the curve and struggling to bring it under control.
Transmission is concentrated in Ituri Province in eastern DRC, but has also reached North Kivu and South Kivu. Nine cases have been confirmed in Uganda. One confirmed case involves a US national who treated patients in DRC and is currently receiving care in Germany — the first indication that the outbreak has reached beyond the African continent.
The Bundibugyo strain adds a layer of particular difficulty. Unlike the better-known Zaire strain — against which vaccines and treatments exist — the Bundibugyo species has no approved medicines or vaccines, though research into candidate treatments is ongoing. Medical teams are managing cases with supportive care alone.
Why Closing the Border Creates Its Own Crisis
Uganda’s decision to close the crossing was made by a local task force rather than the national government. Ugandan health workers had been exposed to the virus through Congolese patients who crossed before the outbreak was formally declared on 15 May. The closure was announced as temporary, with exceptions permitted for humanitarian purposes, outbreak response, cargo and security.
The WHO’s position is unambiguous and grounded in two decades of outbreak evidence: blanket border closures do not stop viruses. They stop the visible, documented movement of people — and redirect it underground. Traders and families who cannot cross legally find ways to cross without screening. Contact tracers cannot follow chains of transmission across a sealed frontier. Medical supplies pile up rather than reaching treatment centres.
There is a secondary cost that rarely appears in the headlines. The DRC-Uganda border corridor is one of the most active commercial routes in central Africa. Eastern DRC’s Ituri Province has been blighted by decades of conflict and humanitarian crisis, and the outbreak has deepened an already dire situation for its population. A border closure compounds that harm — disrupting food supply, blocking medical imports, and eroding the community trust that is, in practice, the most powerful tool any Ebola response possesses.
The $518 Million Plan and What It Must Achieve
WHO and the Africa CDC launched a joint six-month continental response plan running from June to November 2026, with a funding target of $518 million. The plan operates under a unified “One Response” framework — one plan, one budget, one team — covering emergency coordination, disease surveillance, laboratory testing, infection prevention, clinical care, community engagement, logistics, and support for essential health services across both affected and at-risk countries.
The scope of what needs to happen is formidable:
| Response Pillar | Priority Action | Key Challenge |
|---|---|---|
| Surveillance | Contact tracing across three DRC provinces | Insecurity, poor road access in Ituri |
| Diagnostics | Rapid laboratory confirmation | Testing delays; remote geography |
| Treatment | Isolation units, supportive care | No approved Bundibugyo-specific treatment |
| Vaccines | Emergency trials of candidate vaccines | No licensed product yet available |
| Community engagement | Trust-building, messaging | History of attacks on health workers |
| Border health | Targeted screening at official crossings | Closure undermining screening capacity |
| Regional preparedness | Neighbouring-country surveillance | Nine countries share DRC land borders |
Tedros has been direct about the scale of the challenge. “The outbreak is moving fast and we are still playing catch-up,” he said. “Containing Ebola requires political commitment, sustained finances and trust in engaging the communities.”
That last element — trust — is the one least reducible to funding. In eastern DRC, health workers have faced repeated attacks from armed groups suspicious of outside intervention. Treatment tents have been set alight. Contact tracers have been threatened. An Ebola response that alienates the communities it is trying to protect tends to drive cases into hiding rather than into care — the worst possible outcome for containment.
The Global Dimension
For governments and health systems beyond the immediate region, the Bundibugyo outbreak carries lessons that extend well past central Africa.
WHO has advised against any restriction of travel or trade with the DRC or Uganda, with the IHR Emergency Committee’s temporary recommendations emphasising coordinated outbreak control and enhanced cross-border collaboration rather than containment through closure. That guidance reflects hard-won evidence from the 2014-16 West Africa Ebola epidemic — the deadliest in history — where border closures prolonged the crisis by obstructing the very response infrastructure needed to end it.
The CDC has issued a Level 3 Travel Health Notice for DRC and a Level 1 Notice for Uganda, noting that the outbreak is occurring in areas affected by insecurity, population displacement, mining-related mobility and frequent cross-border movement — all of which increase transmission risk. The US government has confirmed it is preparing facilities to receive Americans potentially exposed while working in the affected zone.
Nine countries share land borders with DRC. The WHO’s continental preparedness component of the response plan is not precautionary box-ticking. It is an acknowledgement that the geographic conditions — dense trade routes, significant population mobility, humanitarian displacement from ongoing conflict — make regional spread a genuine and live probability.
What Determines Whether This Is Contained or Becomes Something Worse
The next six to eight weeks are critical. Several variables will shape the trajectory:
Funding speed. A $518 million plan that takes months to capitalise is not the same as one funded rapidly. The gap between a funding announcement and money reaching field operations has historically been a point of failure in outbreak responses.
The border question. Uganda’s decision to reopen — or not — will determine whether contact tracing can function across the most critical transmission corridor. A phased reopening with enhanced screening at official crossings would align with WHO guidance whilst addressing legitimate security concerns.
Community relations in Ituri. Eastern DRC’s history of violence against health workers is not incidental. It is the central operational obstacle. How response teams navigate that environment — whether through community health workers, religious leaders, or local authority engagement — will matter more than any logistical deployment.
Vaccine trials. Work is ongoing to test promising candidate treatments and vaccines for the Bundibugyo strain. If any candidates can be fast-tracked to emergency use authorisation, the response calculus changes significantly. Without them, containment depends entirely on surveillance, isolation, and the kind of community cooperation that border closures tend to undermine.
Ebola does not negotiate with political decisions. It moves through contact, through care, through the ordinary human intimacies of family and community life. Stopping it requires being present where it is — not absent behind a sealed frontier.